However, in cholestasis, reduced FXR activation leads to the upregulation of lipogenic genes and enhanced de novo fatty acid synthesis, while mitochondrial dysfunction further impairs β-oxidation, promoting FFA accumulation [21,22]. This evidence concerns the gene NR1H4 and cholestasis.